首页> 外文期刊>Food Science & Nutrition >Cinnamon extract inhibits angiogenesis in zebrafish and human endothelial cells by suppressing VEGFR1, VEGFR2, and PKC‐mediated MAP kinase
【24h】

Cinnamon extract inhibits angiogenesis in zebrafish and human endothelial cells by suppressing VEGFR1, VEGFR2, and PKC‐mediated MAP kinase

机译:肉桂提取物通过抑制VEGFR1,VEGFR2和PKC介导的MAP激酶来抑制斑马鱼和人内皮细胞的血管生成

获取原文
           

摘要

AbstractAngiogenesis is a process of new blood vessel generation and under pathological conditions, lead to tumor development, progression, and metastasis. Many bioactive components have been studied for its antiangiogenic properties as a preventive strategy against tumor development. This study is focused on the effects of cinnamon extract in modulating the pathway involved in angiogenesis. Human umbilical vein endothelial cells (HUVEC) were treated with cinnamon extract at a concentration of 25 μg/mL for 1, 3, or 6 h followed by treatment with phorbol ester (TPA) at a concentration of 10 nmol/L to induce mitogen-activated protein kinase (MAPK) expression. Results show that cinnamon extract inhibited TPA-induced phosphorylation of MAPK and AKT in a dose-dependent manner. Gene expression results in HUVEC showed that cinnamon extract treatment inhibited TPA induction of protein kinase C, PKCα and PKCη messenger RNA (mRNA) expression in a dose-dependent manner along with suppression of vascular endothelial growth factor receptor 1 (VEGFR1/Flt1) and vascular endothelial growth factor receptor 2 (VEGFR2/KDR/Flk1) mRNA expression. Cinnamon extract was administered to zebrafish embryos during gastrulation at 6–8 h post fertilization (hpf). The embryos were observed for changes in morphology, toxicity, and blood vessel development. The intersegmental vessels in the zebrafish embryos were attenuated and underdeveloped at an effective cinnamon extract dose of 250 μg/mL compared with the DMSO-treated control. Exposure to cinnamon extract for 36 h resulted in gross morphological deformities. The results suggest the effect of cinnamon extract on angiogenesis is mediated by PKC-dependent phosphorylation of MAPK.
机译:摘要血管生成是在病理条件下新生血管生成的过程,导致肿瘤的发生,发展和转移。已经研究了许多生物活性成分的抗血管生成特性,以此作为针对肿瘤发展的预防策略。这项研究的重点是肉桂提取物在调节血管生成相关途径中的作用。将人脐静脉内皮细胞(HUVEC)用肉桂提取物以25μg/ mL的浓度处理1、3或6h,然后用佛波酯(TPA)以10nmol / L的浓度处理以诱导有丝分裂原-激活的蛋白激酶(MAPK)表达。结果显示肉桂提取物以剂量依赖性方式抑制TPA诱导的MAPK和AKT磷酸化。 HUVEC中的基因表达结果表明,肉桂提取物处理以剂量依赖性方式抑制TPA诱导的蛋白激酶C,PKCα和PKCη信使RNA(mRNA)表达,并抑制血管内皮生长因子受体1(VEGFR1 / Flt1)和血管内皮生长因子受体2(VEGFR2 / KDR / Flk1)mRNA表达。肉桂提取物在受精(hpf)后6至8小时的胃胚化过程中施用于斑马鱼的胚胎。观察胚胎的形态,毒性和血管发育的变化。与DMSO处理的对照组相比,在250μg/ mL的有效肉桂提取物剂量下,斑马鱼胚胎中的节间血管减弱并发育不足。暴露于肉桂提取物中36小时会导致总体形变。结果表明肉桂提取物对血管生成的作用是由PKC依赖的MAPK磷酸化介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号